Source: Health Products Regulatory Authority (ZA) Revision Year: 2023 Publisher: Viatris Healthcare (Pty) Ltd, 4 Brewery Street, Isando, Johannesburg, 1600, Gauteng, South Africa
EFRIN (film-coated tablet).
| Pharmaceutical Form |
|---|
|
Peach coloured, capsule shaped, film-coated tablets, debossed with “M109” on one side and plain on the other side. |
Each film-coated tablet contains 600 mg efavirenz.
Contains sugar: Lactose monohydrate 255, 60 mg.
| Active Ingredient | Description | |
|---|---|---|
| Efavirenz |
Efavirenz is a NNRTI of HIV-1. Efavirenz is a non-competitive inhibitor of HIV-1 reverse transcriptase (RT) and does not significantly inhibit HIV-2 RT or cellular DNA polymerases (α, β, γ or δ). |
| List of Excipients |
|---|
|
Cellulose microcrystalline, croscarmellose sodium, hydroxypropyl cellulose, sodium lauryl sulfate, lactose, magnesium stearate, film-coat {hypromellose, titanium dioxide, macrogol/PEG 400, iron oxide yellow, iron oxide red}. |
EFRIN is packed in high density polypropylene (HDPE) bottle pack (marketable pack) comprising of wide mouth white HDPE bottle with a white opaque polypropylene (PP) closure with induction sealing in pack sizes of 30’s packed in a carton.
Viatris Healthcare (Pty) Ltd, 4 Brewery Street, Isando, Johannesburg, 1600, Gauteng, South Africa
45/20.2.8/0169
20 April 2012
| Drug | Countries | |
|---|---|---|
| EFRIN | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
